Literature DB >> 22183805

Inhibition of TLR ligand- and interferon gamma-induced murine microglial activation by Panax notoginseng.

Celine A Beamer1, David M Shepherd.   

Abstract

Among the many products which influence microglial activation and resulting neuroinflammation, herbal medicine has recently drawn much attention due to its immunomodulatory and neuroprotective activities. The purpose of the current study was to investigate the effects of an extract of Panax notoginseng (NotoG™) on TLR ligand- and IFNγ-induced activation in N9 and EOC20 microglial cells lines. NotoG suppressed microglial activation as measured by reduced expression of accessory molecules (CD40 and CD86), decreased production of inflammatory mediators (IL-6 and TNFα), and diminished release of antibacterial products (nitric oxide). Furthermore, this immunosuppressive activity was neither dependent on the glucocorticoid receptor, nor the result of a single ginsenosides (Rb1, Rg1, or Re), which are the major active constituents of the whole extract. NotoG and select ginsenosides may therefore be of therapeutic benefit in treating or preventing neurodegenerative diseases such as multiple sclerosis and parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183805      PMCID: PMC3845666          DOI: 10.1007/s11481-011-9333-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  50 in total

1.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

2.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Bonnie N Dittel
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

Review 3.  Regulation of neuroinflammation by herbal medicine and its implications for neurodegenerative diseases. A focus on traditional medicines and flavonoids.

Authors:  Kyoungho Suk
Journal:  Neurosignals       Date:  2005

4.  Reciprocal activity of ginsenosides in the production of proinflammatory repertoire, and their potential roles in neuroprotection in vivo.

Authors:  Seong Soo Joo; Tae Joon Won; Do Ik Lee
Journal:  Planta Med       Date:  2005-05       Impact factor: 3.352

5.  Ginsenosides may reverse the dexamethasone-induced down-regulation of glucocorticoid receptor.

Authors:  Changquan Ling; Yong Li; Xiaoyan Zhu; Chen Zhang; Min Li
Journal:  Gen Comp Endocrinol       Date:  2004-12-16       Impact factor: 2.822

6.  Effects of Panax notoginseng saponins on posthypoxic cell damage of neurons in vitro.

Authors:  K Y Jiang; Z N Qian
Journal:  Zhongguo Yao Li Xue Bao       Date:  1995-09

7.  Siberian ginseng reduces infarct volume in transient focal cerebral ischaemia in Sprague-Dawley rats.

Authors:  Yungmin Bu; Zhen Hua Jin; Sun Young Park; Sunkyung Baek; Sungju Rho; Nina Ha; Seong Kyu Park; Hocheol Kim
Journal:  Phytother Res       Date:  2005-02       Impact factor: 5.878

8.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation.

Authors:  Seong Soo Joo; Yeong Min Yoo; Byung Woo Ahn; Sang Yun Nam; Yun-Bae Kim; Kwang Woo Hwang; Do Ik Lee
Journal:  Biol Pharm Bull       Date:  2008-07       Impact factor: 2.233

10.  Ginsenoside Rg1 down-regulates glucocorticoid receptor and displays synergistic effects with cAMP.

Authors:  E Chung; K Y Lee; Y J Lee; Y H Lee; S K Lee
Journal:  Steroids       Date:  1998 Jul-Aug       Impact factor: 2.668

View more
  7 in total

Review 1.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

Review 2.  The "Treatise on the spleen and stomach" (Pí Wèi Lùn) as the first record of multiple sclerosis in the medical literature - A hypothesis based on the analysis of clinical presentation and herbal medicine.

Authors:  Andréa D Fuzimoto; Francesco Brigo
Journal:  J Tradit Complement Med       Date:  2020-03-02

Review 3.  Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.

Authors:  Valentina Caputi; Maria Cecilia Giron
Journal:  Int J Mol Sci       Date:  2018-06-06       Impact factor: 5.923

4.  Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells.

Authors:  Xuemei Qiu; Qingqing Guo; Xue Liu; Hui Luo; Danping Fan; Yongqi Deng; Hua Cui; Cheng Lu; Ge Zhang; Xiaojuan He; Aiping Lu
Journal:  Front Pharmacol       Date:  2018-10-31       Impact factor: 5.810

5.  Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.

Authors:  Gagandeep Kaur; Tapan Behl; Simona Bungau; Arun Kumar; Md Sahab Uddin; Vineet Mehta; Gokhan Zengin; Bijo Mathew; Muhammad Ajmal Shah; Sandeep Arora
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

6.  A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.

Authors:  Hee Jin Kim; Pitna Kim; Chan Young Shin
Journal:  J Ginseng Res       Date:  2013-03       Impact factor: 6.060

Review 7.  Therapeutic Potential and Cellular Mechanisms of Panax Notoginseng on Prevention of Aging and Cell Senescence-Associated Diseases.

Authors:  Haiping Zhao; Ziping Han; Guangwen Li; Sijia Zhang; Yumin Luo
Journal:  Aging Dis       Date:  2017-12-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.